Literature DB >> 6208784

Retinal neovascularization and ocular toxoplasmosis.

M W Gaynon, E E Boldrey, E R Strahlman, S L Fine.   

Abstract

Retinal neovascularization, a rare complication of ocular toxoplasmosis, is a source of vitreous hemorrhage. We examined three patients (all women, 70, 36, and 19 years old) with inactive toxoplasmosis scars associated with occlusion of a retinal arteriole or venule passing through the scar, capillary nonperfusion, and adjacent retinal neovascularization. In two patients photocoagulation of the ischemic areas produced a cessation of hemorrhage and the disappearance of neovascularization. In the third case, the neovascular frond was avulsed from its supplying retinal arteriole without treatment.

Entities:  

Mesh:

Year:  1984        PMID: 6208784     DOI: 10.1016/0002-9394(84)90244-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Branch retinal artery occlusion in toxoplasma retinochoroiditis.

Authors:  T H Williamson; P A Meyer
Journal:  Br J Ophthalmol       Date:  1991-04       Impact factor: 4.638

2.  Retinal vascular involvement in acute toxoplasmic retinochoroiditis.

Authors:  P Theodossiadis; S Kokolakis; I Ladas; A C Kollia; D Chatzoulis; G Theodossiadis
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

Review 3.  Ocular toxoplasmosis; common and rare symptoms and signs.

Authors:  P T de Jong
Journal:  Int Ophthalmol       Date:  1989-12       Impact factor: 2.031

4.  Branch retinal artery occlusion caused by toxoplasmosis in an adolescent.

Authors:  Elizabeth Chiang; Debra A Goldstein; Michael J Shapiro; Marilyn B Mets
Journal:  Case Rep Ophthalmol       Date:  2012-10-06

Review 5.  [Ocular toxoplasmosis].

Authors:  U Pleyer; N Torun; O Liesenfeld
Journal:  Ophthalmologe       Date:  2007-07       Impact factor: 1.174

Review 6.  Implications of TORCH Diseases in Retinal Development-Special Focus on Congenital Toxoplasmosis.

Authors:  Viviane Souza de Campos; Karin C Calaza; Daniel Adesse
Journal:  Front Cell Infect Microbiol       Date:  2020-10-26       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.